Jason Filopei, MD
- ASSISTANT PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
- Pulmonary Medicine (Lung)
- Critical Care Medicine
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- New York Eye and Ear Infirmary of Mount Sinai
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Respiratory Institute 212-420-2377 212-420-2377
Jason Filopei, MD, is an Assistant Professor in the Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine. He completed his medical training at New York Medical College in Valhalla, New York and both his Internal Medicine Residency and Pulmonary Critical Care and Sleep Medicine Fellowship at Mount Sinai Beth Israel. He currently is an Assistant Professor of Medicine and serves as the Assistant Director of the Medical Intensive Care Unit at Mount Sinai Beth Israel.
Dr. Jason Filopei's clinical research interests lie in utilizing point of care ultrasound in the critically ill. He has published in peer reviewed journals on use of lung ultrasound in patients with dyspnea and qualitative assessment of the right ventricle in patient's with acute pulmonary embolism. He has served as both regional and international faculty to teach critical care ultrasound through the American College of Chest Physicians. He also co-founded the the Pulmonary Embolism Response Team at Mount Sinai Beth Israel with Dr. David Steiger, a multi-disciplinary service meant to provide rapid, efficient and evidence based care for high risk patients. He serves on several hospital wide committee including Sepsis and Critical Care and currently chairs the Rapid Response Team
Critical Care Medicine
American Board of Internal Medicine
- Acute Respiratory Distress Syndrome (ARDS)
- Bronchial Stenosis
- Chronic Obstructive Pulmonary Disease (COPD)
- Pulmonary Embolism
MD, New York Medical College
Residency, Internal Medicine
Beth Israel Medical Center
Fellowship, Pulmonary & Critical Care
Beth Israel Medical Center
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Filopei did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.